Northern Trust Corp Cue Biopharma, Inc. Transaction History

Northern Trust Corp

$586 Billion
Q2 2024

A detailed history of Northern Trust Corp transactions in Cue Biopharma, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 350,419 shares of CUE stock, worth $157,688. This represents 0.0% of its overall portfolio holdings.

Number of Shares

350,419

Previous 365,182 4.04%

Holding current value

$157,688

Previous $690,000 37.1%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$1.24 - $2.18 $18,306 - $32,183	-14,763 Reduced 4.04%	350,419 $434,000
Q1 2024 May 14, 2024	SELL	$1.77 - $3.09 $28,647 - $50,011	-16,185 Reduced 4.24%	365,182 $690,000
Q4 2023 Feb 13, 2024	BUY	$1.72 - $3.1 $90,613 - $163,314	52,682 Added 16.03%	381,367 $1.01 Million
Q3 2023 Nov 13, 2023	SELL	$2.23 - $4.69 $6,132 - $12,897	-2,750 Reduced 0.83%	328,685 $755,000
Q2 2023 Aug 11, 2023	BUY	$3.11 - $4.91 $787,249 - $1.24 Million	253,135 Added 323.29%	331,435 $1.21 Million
Q1 2023 May 15, 2023	BUY	$2.41 - $3.74 $37,863 - $58,759	15,711 Added 25.1%	78,300 $279,000
Q3 2022 Nov 14, 2022	BUY	$2.23 - $3.37 $4,716 - $7,127	2,115 Added 3.5%	62,589 $139,000
Q2 2022 Aug 12, 2022	SELL	$2.49 - $5.92 $607,241 - $1.44 Million	-243,872 Reduced 80.13%	60,474 $150,000
Q1 2022 May 13, 2022	SELL	$4.41 - $12.28 $53,453 - $148,845	-12,121 Reduced 3.83%	304,346 $1.49 Million
Q4 2021 Feb 08, 2022	BUY	$10.86 - $17.85 $72,729 - $119,541	6,697 Added 2.16%	316,467 $3.58 Million
Q3 2021 Nov 15, 2021	SELL	$10.06 - $15.3 $96,022 - $146,038	-9,545 Reduced 2.99%	309,770 $4.51 Million
Q2 2021 Aug 13, 2021	SELL	$10.9 - $14.53 $124,031 - $165,336	-11,379 Reduced 3.44%	319,315 $3.72 Million
Q1 2021 May 12, 2021	SELL	$11.2 - $16.09 $146,171 - $209,990	-13,051 Reduced 3.8%	330,694 $4.04 Million
Q4 2020 Feb 11, 2021	SELL	$11.12 - $16.4 $42,111 - $62,106	-3,787 Reduced 1.09%	343,745 $4.3 Million
Q3 2020 Nov 16, 2020	SELL	$15.05 - $23.54 $55,474 - $86,768	-3,686 Reduced 1.05%	347,532 $5.23 Million
Q2 2020 Aug 14, 2020	BUY	$12.7 - $30.73 $1.46 Million - $3.53 Million	114,744 Added 48.52%	351,218 $8.61 Million
Q1 2020 May 14, 2020	BUY	$9.85 - $22.27 $161,549 - $365,250	16,401 Added 7.45%	236,474 $3.36 Million
Q4 2019 Feb 14, 2020	SELL	$7.06 - $17.47 $25,267 - $62,525	-3,579 Reduced 1.6%	220,073 $3.49 Million
Q3 2019 Nov 13, 2019	BUY	$6.78 - $9.28 $129,477 - $177,220	19,097 Added 9.34%	223,652 $1.89 Million
Q2 2019 Aug 13, 2019	BUY	$7.18 - $9.65 $28,504 - $38,310	3,970 Added 1.98%	204,555 $1.84 Million
Q1 2019 May 13, 2019	BUY	$4.7 - $9.29 $51,761 - $102,310	11,013 Added 5.81%	200,585 $1.55 Million
Q4 2018 Feb 12, 2019	SELL	$4.35 - $8.73 $6,094 - $12,230	-1,401 Reduced 0.73%	189,572 $891,000
Q3 2018 Nov 14, 2018	BUY	$7.91 - $11.89 $82,952 - $124,690	10,487 Added 5.81%	190,973 $1.73 Million
Q2 2018 Aug 14, 2018	BUY	$10.93 - $14.48 $1.15 Million - $1.53 Million	105,333 Added 140.16%	180,486 $2.14 Million
Q1 2018 May 09, 2018	BUY	$11.63 - $17.25 $874,029 - $1.3 Million	75,153 New	75,153 $1.06 Million

Others Institutions Holding CUE

# of Institutions

Shares Held

13.8M

Call Options Held

56.1K

Put Options Held

11.1K

View Full List

About Cue Biopharma, Inc.

Ticker CUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 35,381,700
Market Cap $15.9M
Description
Cue Biopharma, Inc., a clinical-stage biopharmaceutical company, develops biologic drugs for the selective modulation of the human immune system to treat a range of cancers, chronic infectious diseases, and autoimmune disorders. Its lead drug candidate is CUE-101, a fusion protein biologic that is in Phase 1b clinical trial designed to target an...

More about CUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.

Account

Northern Trust Corp Cue Biopharma, Inc. Transaction History